CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 43(Granted Patents)

Location History:

Newtown, PA (US) (1994 - 1997)
Yardley, PA (US) (1995 - 2000)
St. Louis, MO (US) (2001 - 2006)

Company Filing History:

8 out of 3,681

Bristol-myers Squibb Compnay

patents

4 out of 1,624

E. R. Squibb Sons, Inc.

patents

Years Active: 1994-2006

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7034152 - Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2006-04-25),

2. 6649387 - Enzymatic oxidative deamination process (2003-11-18),

3. 6515170 - Enzymatic oxidative deamination process (2003-02-04),

4. 6261810 - Enzymatic oxidative deamination process (2001-07-17),

5. H001893 - Enzymatic reduction method for the preparation of halohydrins (2000-10-02),

6. 5686298 - Enzymatic reduction method for the preparation of compounds useful for (1997-11-11),

7. H001679 - Process for preparing an optically pure intermediate for a (1997-09-01),

8. 5478734 - Method of chiral epoxidation of benzopyran or pyranopyridine derivatives (1995-12-26),

9. 5420337 - Enzymatic reduction method for the preparation of compounds useful for (1995-05-30),

10. 5393663 - Stereoselective preparation of halophenyl alcohols from ketones (1995-02-28),

11. 5391495 - Stereoselective reduction of ketones (1995-02-21),

12. 5324662 - Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to (1994-06-28),

Title: The Innovative Contributions of Amit Banerjee

Introduction

Amit Banerjee is a prominent inventor based in St. Louis, MO, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable advancements in the development of antiviral agents and other therapeutic compounds. His work has had a substantial impact on the medical community, particularly in the treatment of viral infections.

Latest Patents

Among his latest patents is a process for preparing the antiviral agent entecavir. This patent details processes for the isolation and purification of entecavir, along with various intermediates useful in its preparation. Another notable invention is an enzymatic oxidative deamination process of a dipeptide monomer, which is aimed at preparing intermediates that exhibit endopeptidase and angiotensin-converting enzyme inhibition activity. These innovations highlight his expertise in medicinal chemistry and his commitment to advancing healthcare solutions.

Career Highlights

Amit Banerjee has had a distinguished career, working with renowned companies such as Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His experience in these organizations has allowed him to collaborate with leading scientists and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Amit has worked alongside notable colleagues, including Ramesh N. Patel and Laszlo J. Szarka. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical products.

Conclusion

Amit Banerjee's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as a key innovator in the industry. His work continues to influence the development of effective treatments for viral infections and other medical conditions.

This text is generated by artificial intelligence and may not be accurate.